Joint KDA-IAS Session at 2023 ICDM

Date: 21 October 2023


In this session, speakers will discuss many important topics of anti-diabetic treatment and cardiovascular diseases:

  • Update of KDA guidelines focused on SGLT 2 inhibitor and GLP1 therapy
  • SGLT2 inhibitor and CVOTs
  • GLP 1-based therapy and its effect on CVDs
  • Recent update of familial hypercholestrolemia treatment.